Clinical Trials Logo

Coronary Artery Disease clinical trials

View clinical trials related to Coronary Artery Disease.

Filter by:

NCT ID: NCT02883842 Completed - Clinical trials for Coronary Artery Disease

Cardiovascular Health and Text Messaging-Diabetes Mellitus (CHAT-DM) Study

Start date: August 2016
Phase: N/A
Study type: Interventional

The study is a two-arm, parallel, randomized clinical trial. The purpose of the study is to evaluate the effectiveness of automated mobile phone text message-based intervention for secondary prevention, including lifestyles modification, medication adherence improvement and risk factors control among coronary heart disease (CHD) patients with diabetes. The participants will be randomized into intervention and control groups in a 1:1 ratio. The intervention group will receive 6 pre-designed text messages per week in addition to usual care for 6 months, while the control group will receive usual care.

NCT ID: NCT02881216 Completed - Clinical trials for Coronary Artery Disease

Procedural Advantages of a Novel Drug-Eluting Coronary Stent

Start date: January 2015
Phase: N/A
Study type: Interventional

This study sought to compare procedural performance of a new coronary stent generation, that is already available in Germany, with hitherto established current drug-eluting stents.

NCT ID: NCT02879032 Completed - Clinical trials for Stable Ischemic Heart Disease

A Comparative Study of Different Treadmill Scores to Diagnose Coronary Artery Disease

Start date: July 2016
Phase:
Study type: Observational

Exercise treadmill test (ETT) is frequently done, inexpensive, relatively safe investigation for diagnosis of ischemic heart disease and prediction of exercise capacity. Ischemic heart disease is increasing by leaps and bounds all over the world even in the developing countries like Bangladesh. The incidence rate of coronary artery disease (CAD) is not limited to male gender as previously seen. As a cause of industrialization and increased life expectancy, incidence of ischemic heart disease in females is escalating now in Bangladesh also. Though ETT is a well accepted investigation to diagnose CAD, it has a high false positive and false negative result if ST segment response alone is calculated for interpretation of the test. Duke Treadmill Test and Simple Treadmill Test are valid and well known scores which can predict coronary artery disease burden more efficiently than ST segment response alone. Computer generated Cleveland clinic score is another valid treadmill score which has a complex algorithm but effective way to predict 3 year and 5 year survivability. These three scores are well tested on western population but to our best knowledge there is little or no information regarding their predictability of CAD in Bangladesh. It's well known that ETT has a high false positive result in female population, so applying the scores may render ETT more efficient and abrogate unwanted risk of undergoing coronary angiography to diagnose CAD in females. In this study the investigator will try to find out the accuracy of commonly applied treadmill scores and ST segment response to diagnose CAD as well as accuracy of computer generated Cleveland Clinic Score will be tested. Total 110 people including male and female will be included according to inclusion and exclusion criteria and informed written consent will be taken. The patients who have undergone ETT and coronary angiogram with in six months for confirmation and identification of coronary artery disease in accordance with the recommendation of ACC guideline for CAG will be selected . All available data will be analyzed using SPSS. The accuracy of different scores will be calculated and compared with each other. According to currently available data from studies in western population the treadmill scores will have good predictability and will be efficient to abolish high false positive result in female population in Bangladesh.

NCT ID: NCT02876263 Completed - Clinical trials for Coronary Artery Disease

Noninvasive Neuromonitoring of Surgery of the Thoracic Aorta

Start date: September 2007
Phase: N/A
Study type: Observational

The aim of this prospective, explorative study of noninvasive neuromonitoring was to search potential and practical methods associated with neurological outcome in the perioperative and immediate postoperative setting of surgery of the thoracic aorta. These methods include abbreviated EEG monitoring, near-infrared spectroscopy, transcranial Doppler ultrasound and biochemical markers associated with neuronal damage.

NCT ID: NCT02874287 Completed - Clinical trials for Coronary Artery Disease

Efficacy Study of Hydroxychloroquine to Treat High-risk Coronary Artery Disease.

CHANGAN
Start date: October 8, 2017
Phase: Phase 4
Study type: Interventional

The purpose of this study is to evaluate whether treated with hydroxychloroquine could improve therapeutic effect for patients with high-risk coronary artery disease.

NCT ID: NCT02873871 Completed - Clinical trials for Coronary Artery Disease With Myocardial Infarction

Comparison of 2 Hemostasis Techniques After Transradial Coronary

Start date: August 2015
Phase: N/A
Study type: Interventional

Randomized clinical trial to compare radial artery patency after transradial coronary catheterization using 2 different hemostasis techniques. Patients submitted to diagnostic or therapeutic coronary catheterization will be prospectively enrolled in this single-center trial and will be randomized to radial hemostasis with TerumoBand® or a standardized compressive dressing with gauze and elastic bandage.

NCT ID: NCT02873052 Completed - Atherosclerosis Clinical Trials

MyoVista Measurements in Patients With Atherosclerosis and CAD

Start date: September 1, 2015
Phase:
Study type: Observational

The MyoVista system is a novel electrocardiogram technology that provides non‐invasive assessment of myocardial abnormalities by analyzing energy changes at the cellular level of the myocardium.

NCT ID: NCT02870985 Completed - Clinical trials for Coronary Artery Disease

BIOTRONIK Orsiro Pre-Marketing Registration

BIOFLOW-VI
Start date: July 14, 2015
Phase: N/A
Study type: Interventional

The clinical investigation is a non-inferiority, multicenter, blinding evaluation, randomized, parallel controlled clinical study enrolling up to 440 subjects. All subjects will be randomized 1:1 to receive the BIOTRONIK Orsiro SES or the Abbott Xience Prime™ EES, in order to evaluate the efficacy and safety of the SES drug eluting stent in the treatment of coronary artery disease.

NCT ID: NCT02870933 Completed - Clinical trials for Coronary Artery Disease

Transepicardial With Transseptal Autologous CD 133+ Bone Marrow Cell Implantation in Patient Following CABG Surgery

Start date: January 2016
Phase: Phase 4
Study type: Interventional

Heart Failure has several etiologies and one of them is coronary artery disease. Coronary artery bypass grafting (CABG) is one of revascularizations method which has been used for decades in coronary artery disease theraphy. However, data about coronary artery bypass grafting shows that post-CABG patients still have low ejection fraction. For the last decade, there have been a lot of studies about the using of stem cells to increase heart contractility and reverse the heart remodelling process. In this study, we use CD 133+ bone marrow stem cells which has been proved to have higher angiogenesis potential. The stem cells is given during CABG by injection transepicardial and transseptal. The purpose of this study is to determine whether transpicardial and transseptal injection of CD 133+ bone marrow stem cells can improve myocardial perfusion in patient with low ejection fraction following CABG surgery.

NCT ID: NCT02862522 Completed - Clinical trials for Coronary Artery Disease

Uric Acid Levels and Endothelial Functions

Start date: January 1992
Phase: N/A
Study type: Observational

Uric acid is a risk factor for coronary artery disease (CED) in postmenopausal women but the association with inflammation and coronary microvascular endothelial dysfunction is not well-defined. The aim of this study was to determine the relationship of serum uric acid, inflammatory markers and CED.